ERIC BRYCE MANN
- Type
- Physician · Allopathic & Osteopathic Physicians / Ophthalmology
- Where
- DOVER, NJ
- NPI
- 1508847930
- Received
- $632,524 in 1,667 records, 2019 to 2025 ($604,042 general, $28,482 research)
- As principal investigator
- $255,554 of research payments to others in 48 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 282 | $83,383 |
| 2025 | Research payment | 5 | $23,250 |
| 2024 | General payment | 268 | $87,017 |
| 2024 | Research payment | 6 | $5,232 |
| 2023 | General payment | 297 | $129,325 |
| 2022 | General payment | 345 | $166,672 |
| 2021 | General payment | 222 | $89,651 |
| 2020 | General payment | 107 | $13,016 |
| 2019 | General payment | 135 | $34,976 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 124 | $316,054 |
| Compensation for serving as faculty or as a speaker for a medical education program | 37 | $97,262 |
| Consulting Fee | 46 | $77,030 |
| Food and Beverage | 1,283 | $43,623 |
| Travel and Lodging | 147 | $41,842 |
| Research payment | 11 | $28,482 |
| Honoraria | 10 | $15,746 |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing | 5 | $12,200 |
| Education | 3 | $237 |
| Gift | 1 | $45 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-22 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-19 | Bausch & Lomb Americas Inc. | $14 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-12-19 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-12-18 | Tarsus Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-12-17 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-12-16 | NEW WORLD MEDICAL,INC. | $10,625 | Research payment | Cash or cash equivalent | Streamline Device, Ophthalmology | Streamline Retrospective Study | 2025 |
| 2025-12-16 | Alcon Vision LLC | $26 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-12-15 | Alcon Vision LLC | $2 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-12-12 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-12-11 | Mallinckrodt Hospital Products Inc. | $16 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-12-10 | Sight Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-12-09 | Sight Sciences, Inc. | $136 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-12-05 | Harrow Eye, LLC | $18 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-12-04 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-12-03 | Bausch & Lomb Americas Inc. | $1,400 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-12-03 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-12-01 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-11-20 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-20 | Alcon Vision LLC | $6 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-11-19 | ABBVIE INC. | $3,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-18 | TOPCON HEALTHCARE, INC. | $349 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-11-13 | Bausch & Lomb Americas Inc. | $2,800 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-11-13 | ABBVIE INC. | $675 | Consulting Fee | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-13 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-11-12 | Alcon Vision LLC | $122 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-11-11 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-11-10 | Tarsus Pharmaceuticals, Inc. | $9 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-11-07 | Alcon Vision LLC | $27 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-11-07 | BIOTISSUE HOLDINGS INC. | $3 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-11-06 | Alcon Vision LLC | $375 | Consulting Fee | Cash or cash equivalent | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-11-06 | Bausch & Lomb Americas Inc. | $125 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-11-06 | Bausch & Lomb Americas Inc. | $124 | Travel and Lodging | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-11-06 | Bausch & Lomb Americas Inc. | $8 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-11-05 | Bausch & Lomb Americas Inc. | $2,800 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-11-05 | ABBVIE INC. | $120 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-11-05 | Ocular Therapeutix, Inc. | $16 | Food and Beverage | In-kind items and services | DEXTENZA Drug, Corticosteroid intracanalicular insert | 2025 | |
| 2025-11-05 | Sight Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-11-05 | Bausch & Lomb Americas Inc. | $15 | Food and Beverage | In-kind items and services | ScoutPro Osmolarity System Device, Ophthalmology | 2025 | |
| 2025-11-04 | Oyster Point Pharma, Inc. | $19 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2025 | |
| 2025-11-03 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-11-03 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-11-03 | Sight Sciences, Inc. | $6 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-10-31 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-31 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-30 | BIOTISSUE HOLDINGS INC. | $106 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-29 | Bausch & Lomb Americas Inc. | $111 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-10-29 | Bausch & Lomb Americas Inc. | $96 | Travel and Lodging | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-10-27 | Bausch & Lomb Americas Inc. | $4 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-10-24 | SUN PHARMACEUTICAL INDUSTRIES INC. | $18 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-10-23 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-22 | Bausch & Lomb Americas Inc. | $875 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-10-22 | Alcon Vision LLC | $17 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-10-22 | Alcon Vision LLC | $15 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-10-20 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-10-20 | Dompe US, Inc. | $0 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-10-19 | ABBVIE INC. | $44 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-18 | Harrow Eye, LLC | $27 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-10-17 | Bausch & Lomb Americas Inc. | $1,400 | Consulting Fee | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-10-17 | Bausch & Lomb Americas Inc. | $70 | Consulting Fee | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-10-17 | Mallinckrodt Hospital Products Inc. | $51 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-10-17 | Tarsus Pharmaceuticals, Inc. | $26 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-10-16 | BIOTISSUE HOLDINGS INC. | $4 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-15 | Mallinckrodt Hospital Products Inc. | $141 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-10-09 | Bausch & Lomb Americas Inc. | $38 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-10-08 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-10-08 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-06 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-10-03 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-10-03 | Oyster Point Pharma, Inc. | $16 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2025 | |
| 2025-10-03 | Sight Sciences, Inc. | $11 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-10-01 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-09-29 | Tarsus Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-09-29 | Bausch & Lomb Americas Inc. | $15 | Food and Beverage | In-kind items and services | ScoutPro Osmolarity System Device, Ophthalmology | 2025 | |
| 2025-09-25 | ABBVIE INC. | $4,725 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-09-25 | Harrow Eye, LLC | $15 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-09-24 | Glaukos Corporation | $4,625 | Consulting Fee | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-09-22 | Johnson & Johnson Surgical Vision, Inc. | $16 | Food and Beverage | In-kind items and services | TECNIS IOL Device, Optics | 2025 | |
| 2025-09-19 | BIOTISSUE HOLDINGS INC. | $20 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-17 | Oyster Point Pharma, Inc. | $16 | Food and Beverage | In-kind items and services | TYRVAYA Drug, Dry eyes | 2025 | |
| 2025-09-17 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-09-16 | NEW WORLD MEDICAL,INC. | $5,250 | Research payment | Cash or cash equivalent | Streamline Device, Ophthalmology | Streamline Retrospective Study | 2025 |
| 2025-09-16 | ABBVIE INC. | $850 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-09-16 | ABBVIE INC. | $121 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-09-15 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-09-12 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-09-11 | Sight Sciences, Inc. | $8 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-09-11 | Sight Sciences, Inc. | $8 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-09-11 | Bausch & Lomb Americas Inc. | $4 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-09-10 | Alcon Vision LLC | $2 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-09-09 | Glaukos Corporation | $211 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-09-09 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-09-05 | SUN PHARMACEUTICAL INDUSTRIES INC. | $17 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-09-03 | Harrow Eye, LLC | $138 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-09-03 | Alcon Vision LLC | $27 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-09-03 | Alcon Vision LLC | $6 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-08-29 | Harrow Eye, LLC | $20 | Food and Beverage | In-kind items and services | VEVYE Drug, OPTOMETRY | 2025 | |
| 2025-08-28 | Mallinckrodt Hospital Products Inc. | $99 | Education | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-08-28 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-08-28 | SUN PHARMACEUTICAL INDUSTRIES INC. | $16 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-08-27 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-08-26 | Dompe US, Inc. | $51 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-08-26 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-08-26 | Alcon Vision LLC | $12 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-08-26 | Dompe US, Inc. | $10 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-08-25 | Tarsus Pharmaceuticals, Inc. | $120 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-08-22 | Sight Sciences, Inc. | $20 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-08-20 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-20 | Alcon Vision LLC | $9 | Food and Beverage | In-kind items and services | Clareon PanOptix Pro Device, Ophthalmology | 2025 | |
| 2025-08-20 | BIOTISSUE HOLDINGS INC. | $6 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-19 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-08-18 | BIOTISSUE HOLDINGS INC. | $3 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-08-15 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-08-15 | Dompe US, Inc. | $8 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-08-14 | ABBVIE INC. | $2,025 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-08-08 | NEW WORLD MEDICAL,INC. | $875 | Research payment | Cash or cash equivalent | Streamline Device, Ophthalmology | Streamline Retrospective Study | 2025 |
| 2025-08-06 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-08-06 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-05 | Alcon Vision LLC | $96 | Food and Beverage | In-kind items and services | TRYPTYR Drug, Ophthalmology | 2025 | |
| 2025-07-31 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-07-28 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-07-28 | Dompe US, Inc. | $8 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-07-25 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-07-25 | BIOTISSUE HOLDINGS INC. | $4 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-24 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-07-23 | SUN PHARMACEUTICAL INDUSTRIES INC. | $18 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-07-22 | Bausch & Lomb Americas Inc. | $10 | Food and Beverage | In-kind items and services | ScoutPro Osmolarity System Device, Ophthalmology | 2025 | |
| 2025-07-21 | Thea Pharma Inc. | $19 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2025 | |
| 2025-07-16 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-07-08 | BIOTISSUE HOLDINGS INC. | $5 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-07-08 | Bausch & Lomb Americas Inc. | $3 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-07-07 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-07-03 | Dompe US, Inc. | $12 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-07-01 | Bausch & Lomb Americas Inc. | $2,800 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-30 | Ocular Therapeutix, Inc. | $2,500 | Research payment | Cash or cash equivalent | A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTX-TIC | 2025 | |
| 2025-06-26 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-06-25 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-06-24 | Alcon Vision LLC | $94 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-06-23 | Glaukos Corporation | $3,000 | Consulting Fee | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-06-23 | Thea Pharma Inc. | $19 | Food and Beverage | In-kind items and services | IYUZEH Drug, OPHTHALMOLOGY | 2025 | |
| 2025-06-20 | Ocular Therapeutix, Inc. | $750 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | DEXTENZA Drug, Corticosteroid intracanalicular insert | 2025 | |
| 2025-06-19 | Alcon Vision LLC | $15 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-06-18 | Tarsus Pharmaceuticals, Inc. | $19 | Food and Beverage | In-kind items and services | XDEMVY Drug, DEMODEX BLEPHARITIS | 2025 | |
| 2025-06-16 | Bausch & Lomb Americas Inc. | $2,800 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-13 | SUN PHARMACEUTICAL INDUSTRIES INC. | $16 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-06-12 | Glaukos Corporation | $152 | Food and Beverage | Cash or cash equivalent | iDoseTR Drug, Ophthalmology | 2025 | |
| 2025-06-12 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-06-11 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-10 | Bausch & Lomb Americas Inc. | $126 | Travel and Lodging | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-10 | Bausch & Lomb Americas Inc. | $125 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-09 | Alcon Vision LLC | $18 | Food and Beverage | In-kind items and services | EYSUVIS Drug, Ophthalmology | 2025 | |
| 2025-06-06 | NEW WORLD MEDICAL,INC. | $4,000 | Research payment | Cash or cash equivalent | Streamline Device, Ophthalmology | Streamline Retrospective Study | 2025 |
| 2025-06-06 | ABBVIE INC. | $3,375 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-06-06 | ANI Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-06-05 | Bausch & Lomb Americas Inc. | $250 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | XIIDRA Drug, Ophthalmology | 2025 | |
| 2025-06-05 | BIOTISSUE HOLDINGS INC. | $3 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-06-03 | Bausch & Lomb Americas Inc. | $199 | Travel and Lodging | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-03 | Bausch & Lomb Americas Inc. | $195 | Travel and Lodging | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-03 | Bausch & Lomb Americas Inc. | $115 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-06-03 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-06-02 | ABBVIE INC. | $118 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-06-02 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-05-30 | Dompe US, Inc. | $18 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-05-29 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-28 | Glaukos Corporation | $4,800 | Consulting Fee | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-05-28 | Glaukos Corporation | $974 | Travel and Lodging | Cash or cash equivalent | Travoprost Intraocular Implant - iDose Drug, Ophthalmology | 2025 | |
| 2025-05-27 | RxSight Inc | $140 | Food and Beverage | In-kind items and services | RXSIGHT CONTACT LENS Device, OPHTHALMOLOGY | 2025 | |
| 2025-05-27 | Alcon Vision LLC | $17 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-05-22 | Dompe US, Inc. | $17 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-05-21 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-21 | ABBVIE INC. | $53 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-21 | ABBVIE INC. | $10 | Travel and Lodging | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-20 | Bausch & Lomb Americas Inc. | $2,800 | Consulting Fee | Cash or cash equivalent | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-05-19 | Ocular Therapeutix, Inc. | $1,500 | Consulting Fee | Cash or cash equivalent | DEXTENZA Drug, Corticosteroid intracanalicular insert | 2025 | |
| 2025-05-19 | Bausch & Lomb Americas Inc. | $700 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-05-19 | Mallinckrodt Hospital Products Inc. | $16 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | Alcon Vision LLC | $15 | Food and Beverage | In-kind items and services | Rocklatan Drug, Ophthalmology | 2025 | |
| 2025-05-14 | Bausch & Lomb Americas Inc. | $13 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-05-13 | Bausch & Lomb Americas Inc. | $1,750 | Consulting Fee | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-05-12 | SUN PHARMACEUTICAL INDUSTRIES INC. | $1,340 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Cequa Drug, Ophthalmology | 2025 | |
| 2025-05-12 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-05-12 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | LUMIGAN Drug, EYE CARE | 2025 | |
| 2025-05-09 | ANI Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-09 | BIOTISSUE HOLDINGS INC. | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-07 | Mallinckrodt Hospital Products Inc. | $138 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-05-06 | Alcon Vision LLC | $24 | Food and Beverage | In-kind items and services | Clareon Device, Ophthalmology | 2025 | |
| 2025-05-05 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-02 | SUN PHARMACEUTICAL INDUSTRIES INC. | $17 | Food and Beverage | In-kind items and services | Cequa Drug, Ophthalmology | 2025 | |
| 2025-04-30 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | DURYSTA Drug, EYE CARE | 2025 | |
| 2025-04-28 | Bausch & Lomb Americas Inc. | $2,800 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-04-27 | Bausch & Lomb Americas Inc. | $93 | Food and Beverage | In-kind items and services | MIEBO Drug, Ophthalmology | 2025 | |
| 2025-04-27 | Sight Sciences, Inc. | $33 | Food and Beverage | In-kind items and services | OMNI SURGICAL SYSTEM Device, Ophthalmology | 2025 | |
| 2025-04-27 | Mallinckrodt Hospital Products Inc. | $26 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-04-26 | Tarsus Pharmaceuticals, Inc. | $28 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-25 | Ocular Therapeutix, Inc. | $175 | Food and Beverage | In-kind items and services | DEXTENZA Drug, Corticosteroid intracanalicular insert | 2025 | |
| 2025-04-25 | Dompe US, Inc. | $131 | Food and Beverage | In-kind items and services | OXERVATE Drug, SOLUTION/ DROPS | 2025 | |
| 2025-04-25 | ABBVIE INC. | $42 | Food and Beverage | In-kind items and services | XEN GLAUCOMA TREATMENT SYSTEM Device, EYE CARE | 2025 | |
| 2025-04-22 | Bausch & Lomb Americas Inc. | $16 | Food and Beverage | In-kind items and services | ScoutPro Osmolarity System Device, Ophthalmology | 2025 | |
| 2025-04-22 | Bausch & Lomb Americas Inc. | $13 | Food and Beverage | In-kind items and services | VYZULTA Drug, Ophthalmology | 2025 | |
| 2025-04-21 | Bausch & Lomb Americas Inc. | $2,800 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | MIEBO Drug, Ophthalmology | 2025 |
The latest 200 records of 1,667.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-12-31 | ABBVIE INC. | EYE ASSOCIATES OF NORTH JERSEY | $10,315 | An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma | 2025 |
| 2025-12-04 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $4,524 | TTAX03-CR010 | 2025 |
| 2025-11-07 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $750 | TTAX03-CR010 | 2025 |
| 2025-11-07 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $5,395 | TTAX03-CR010 | 2025 |
| 2025-10-06 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $750 | TTAX03-CR010 | 2025 |
| 2025-10-06 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $750 | TTAX03-CR010 | 2025 |
| 2025-10-06 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $17,976 | TTAX03-CR010 | 2025 |
| 2025-10-06 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $750 | TTAX03-CR010 | 2025 |
| 2025-09-05 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $3,964 | TTAX03-CR010 | 2025 |
| 2025-08-22 | Astellas Pharma Global Development | Eye Associates of North Jersey PA | $7,793 | A Non-interventional, Observational Study to Evaluate Treatment Patterns and Safety of Avacincaptad Pegol (ACP/IZERVAY) | 2025 |
| 2025-08-06 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $904 | TTAX03-CR010 | 2025 |
| 2025-07-07 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $3,059 | TTAX03-CR010 | 2025 |
| 2025-07-07 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $750 | TTAX03-CR010 | 2025 |
| 2025-07-07 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $500 | TTAX03-CR010 | 2025 |
| 2025-06-06 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $750 | TTAX03-CR010 | 2025 |
| 2025-05-09 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $1,017 | TTAX03-CR010 | 2025 |
| 2025-04-09 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $3,228 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2025 |
| 2025-04-04 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $750 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2025 |
| 2025-03-04 | Bausch & Lomb Americas Inc. | EYE ASSOCIATES OF NORTH JERSEY | $4,440 | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspir | 2025 |
| 2025-02-07 | BIOTISSUE HOLDINGS INC. | EYE ASSOCIATES OF NORTH JERSEY | $6,750 | TTAX03-CR010 | 2025 |
| 2025-01-02 | Bausch & Lomb Americas Inc. | EYE ASSOCIATES OF NORTH JERSEY | $3,996 | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista® Aspir | 2025 |
| 2024-12-31 | ABBVIE INC. | Eye Associates of North Jersey PA | $17,684 | 1698-302-007 Ph3 Extension Study (M21-489) | 2024 |
| 2024-11-01 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $18,136 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2024 |
| 2024-10-31 | Bausch & Lomb Americas Inc. | EYE ASSOCIATES OF NORTH JERSEY | $5,994 | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista Aspire | 2024 |
| 2024-09-27 | Bausch & Lomb Americas Inc. | EYE ASSOCIATES OF NORTH JERSEY | $1,998 | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista Aspire | 2024 |
| 2024-07-26 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $34,245 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2024 |
| 2024-07-05 | ABBVIE INC. | Eye Associates of North Jersey PA | $7,760 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) | 2024 |
| 2024-06-28 | Bausch & Lomb Americas Inc. | EYE ASSOCIATES OF NORTH JERSEY | $3,000 | A Non-interventional, Prospective, Multicenter, Single Arm, Post-Marketing Clinical Study to Evaluate the enVista Aspire | 2024 |
| 2024-04-19 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $1,036 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2024 |
| 2024-04-05 | ABBVIE INC. | Eye Associates of North Jersey PA | $236 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) | 2024 |
| 2024-03-15 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $5,000 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2024 |
| 2024-03-15 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $3,975 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2024 |
| 2024-02-21 | Dompe Farmaceutici S.p.A. | EYE ASSOCIATES OF NORTH JERSEY | $1,620 | A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle- Controlled, Parallel Group Study With 4 Weeks of Fo | 2024 |
| 2024-01-04 | ABBVIE INC. | Eye Associates of North Jersey PA | $2,746 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) | 2024 |
| 2023-12-31 | Ocular Therapeutix, Inc. | Eye Associates of North Jersey, PA | $9,000 | A prospective, multi-center, randomized, parallel-group, controlled study to evaluate the efficacy and safety of OTX-TIC | 2023 |
| 2023-11-07 | ABBVIE INC. | Eye Associates of North Jersey PA | $4,496 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) | 2023 |
| 2023-08-09 | ABBVIE INC. | Eye Associates of North Jersey PA | $3,506 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) | 2023 |
| 2023-07-03 | ABBVIE INC. | Eye Associates of North Jersey PA | $7,945 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) | 2023 |
| 2023-02-02 | ABBVIE INC. | Eye Associates of North Jersey PA | $3,519 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) (ARGOS) | 2023 |
| 2023-02-02 | ABBVIE INC. | Eye Associates of North Jersey PA | $8,000 | Long-term Safety and Efficacy Extension Trial of Bimatoprost SR | 2023 |
| 2022-10-13 | Oyster Point Pharma, Inc. | Eye Associates of North Jersey PA | $300 | A PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-0 | 2022 |
| 2022-10-13 | ABBVIE INC. | Eye Associates of North Jersey PA | $8,436 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) | 2022 |
| 2022-10-11 | ABBVIE INC. | Eye Associates of North Jersey PA | $1,500 | Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopi | 2022 |
| 2022-09-08 | ABBVIE INC. | Eye Associates of North Jersey PA | $6,500 | Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopi | 2022 |
| 2022-07-22 | ABBVIE INC. | Eye Associates of North Jersey PA | $10,863 | 18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) | 2022 |
| 2022-06-30 | Oyster Point Pharma, Inc. | EYE ASSOCIATES OF NORTH JERSEY PA | $2,798 | A PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-0 | 2022 |
| 2022-06-30 | Oyster Point Pharma, Inc. | EYE ASSOCIATES OF NORTH JERSEY PA | $5,000 | A PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-0 | 2022 |
| 2022-06-23 | Oyster Point Pharma, Inc. | Eye Associates of North Jersey PA | $1,142 | A PHASE 2, MULTICENTER, RANDOMIZED, CONTROLLED, DOUBLE-MASKED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF OC-0 | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Dover, NJ, county Morris County, NJ, state New Jersey; placed by its city name.
| Measure | Place (city or town) Dover, NJ | County Morris County, NJ | State New Jersey |
|---|---|---|---|
| Population B01003 | 18,563 | 514,528 | 9,343,809 |
| Population, 2020 census P1 | 18,460 | 509,285 | 9,288,994 |
| Median age B01002 | 39.8 | 42.6 | 40.1 |
| Under 18 B01001 | 19.3% | 20.6% | 21.8% |
| 65 and over B01001 | 15.4% | 18.2% | 17.2% |
| Households B11001 | 6,661 | 193,245 | 3,507,701 |
| Foreign born B05002 | 50.5% | 19.8% | 23.9% |
| Median household income B19013 | $73,737 | $137,326 | $103,556 |
| Median family income B19113 | $74,471 | $169,844 | $127,025 |
| Per capita income B19301 | $34,245 | $71,044 | $54,253 |
| Poverty rate B17001 | 14.2% | 4.9% | 9.7% |
| Unemployment rate B23025 | 5.9% | 5.2% | 6.3% |
| Civilian labor force B23025 | 11,309 | 288,525 | 5,003,179 |
| Mean commute (minutes) B08013 | 26.4 | 29.8 | 30.5 |
| Bachelor's degree or higher B15003 | 17.3% | 57.8% | 43.6% |
| Housing units B25001 | 6,831 | 199,506 | 3,791,354 |
| Owner-occupied B25003 | 46.0% | 74.3% | 63.8% |
| Renters B25003 | 54.0% | 25.7% | 36.2% |
| Median home value B25077 | $366,700 | $582,500 | $454,400 |
| Median gross rent B25064 | $1,825 | $1,904 | $1,720 |
| White, not Hispanic B03002 | 12.8% | 65.8% | 50.9% |
| Black B03002 | 3.8% | 3.0% | 12.2% |
| Hispanic or Latino B03002 | 76.4% | 16.0% | 22.5% |
| Asian B03002 | 2.1% | 10.7% | 10.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Dover, NJ.
Comments